EIT Pharma raises $35.0M Series A (United States, Aug 2026)

$35.0M
$35M Series A

Find the investors funding Health Series A rounds

326,000+ verified VCs, angels and family offices — direct emails, check sizes and stage filters.

Find your investors →
Generated social card
EIT Pharma social card
Headline

Kirkland’s EIT Pharma Closes Oversubscribed $35M Series A Round - 425business.com

About

EIT Pharma is a company focused on developing innovative pharmaceutical solutions. The company aims to address unmet medical needs in various therapeutic areas. This funding round will help accelerate their product development and market entry.

Article summary

Kirkland’s EIT Pharma Closes Oversubscribed $35M Series A Round  425business.com

Investors
Related rounds
Aug 31, 2026Aeris Biosciences$3.4MSeedUnited States
Aug 31, 2026Easy Aerial$20.0MSeries BUnited States
Aug 31, 2026Blank Street$105.0MUnited States
Aug 31, 2026RQD Clearing$74.0MMinority Growth InvestmentUnited States

20,048 investors back startups in United States

You just read who funded EIT Pharma. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.

Free account: 5 investor contact unlocks a month, no card required.

About the investors in United States

EIT Pharma raises $35.0M Series A (United States, August 2026) | Datapile